QICAOGANGMU for Hives and Pruritus: What the Evidence Shows
Evidence-informed hives and itch guide
Hives and pruritus are not the same thing. Hives are raised, temporary welts caused by mast-cell mediators such as histamine, while pruritus simply means itch and can have many different causes. Understanding the difference matters because treatment depends on the cause.
Quick reference: hives and itch
| Topic | What is established | What this means | Evidence |
|---|---|---|---|
| Acute hives | Second-generation H1 antihistamines are standard first-line treatment | They target the histamine pathway that drives many urticaria symptoms | PMID 34536239 |
| Chronic urticaria | Symptoms recurring for more than 6 weeks meet the usual definition of chronic urticaria | Persistent hives deserve clinical assessment and may need step-up therapy | PMID 41182242 |
| Pruritus | Itch is a symptom, not a diagnosis | Treatment depends on what is causing the itch | Clinical assessment |
| Cooling pathways | TRPM8-activating creams have shown anti-itch effects in human skin research | Cooling receptors are a genuine target in itch research | PMID 30067875 |
Understanding hives and pruritus
Hives, or urticaria, are raised itchy welts that can appear and disappear quickly. Individual welts usually fade within 24 hours, although new ones can continue to form. Chronic urticaria refers to recurrent symptoms lasting more than six weeks.
Pruritus is simply the medical word for itch. It can occur with a visible rash, such as eczema or hives, or without a visible rash. Persistent generalized itch can also have medication-related, neurologic, liver, kidney or other systemic causes.
Common triggers and causes
- Foods, medications, insect stings and latex in some allergic reactions
- Physical triggers such as pressure, heat, cold or exercise
- Viral or other infections
- Autoimmune processes in some chronic spontaneous urticaria
- Unknown triggers, which are common in chronic urticaria
What current treatment guidance says
The international urticaria guideline recommends second-generation H1 antihistamines as first-line therapy. PMID 34536239
A 2025 clinical practice guideline for H1-antihistamine-resistant chronic spontaneous urticaria also notes that international guidelines use second-generation H1 antihistamines as first-line treatment and provides a stepwise approach for people whose symptoms remain uncontrolled. PMID 41182242
What this means: recurrent hives are not just a topical-skin problem. When antihistamines are not enough, there are evidence-based next steps that should be discussed with a clinician.
What ingredient research tells us about itch
She Chuang Zi and osthole
Osthole, a compound from Cnidium monnieri, reduced scratching in mouse itch models by blocking TRPV3, a receptor involved in itch sensation. PMID 30108138
What this means: one of Cnidium's key compounds has a clear positive effect in experimental itch research.
Menthol and cooling receptors
Menthol activates TRPM8, one of the body's cold-sensing receptors. A clinical study using a different TRPM8-activating cream reported anti-itch effects in people with atopic dermatitis. PMID 30067875
What this means: cooling pathways have real human research behind them, helping explain why cooling ingredients are often studied for itchy or uncomfortable skin.
Borneol
In a randomized, double-blind, placebo-controlled human study, topical borneol produced significantly greater postoperative pain relief than placebo. The study also identified TRPM8 as an important target. PMC5452010
What this means: borneol has human evidence for topical sensory effects, not only laboratory research.
Where QICAOGANGMU fits
QICAOGANGMU is a steroid-free botanical topical containing Cnidii Fructus, Borneolum Syntheticum, Sophorae Flavescentis Radix, Stemonae Radix and Menthol. The ingredient research above gives the formula a clear scientific context around itch, cooling sensation and skin comfort.
Read the ingredient and safety reviewWhen to seek medical help
- Hives with breathing difficulty, throat or tongue swelling, faintness or severe dizziness require emergency care
- Hives recurring for more than six weeks should be assessed as possible chronic urticaria
- Welts that last more than 24 hours, bruise, hurt rather than itch, or occur with fever or joint pain may need a different diagnosis considered
- Persistent generalized itch without a clear rash deserves assessment because causes can extend beyond the skin
TCM perspective on hives and itch
Traditional Chinese Medicine may describe hives or itch using patterns such as Wind-Heat, Wind-Cold, Damp-Heat or Blood Deficiency. These are traditional pattern descriptions rather than biomedical diagnoses.
The most useful way to discuss TCM and modern research together is to describe the traditional pattern first, then separately explain what modern studies found about individual herbs or compounds.
Frequently asked questions
What is the usual first-line treatment for hives?
Second-generation H1 antihistamines are the standard first-line treatment in international urticaria guidance.
When are hives considered chronic?
When wheals, angioedema or both keep recurring for more than six weeks, the condition is generally classified as chronic urticaria.
Can cooling ingredients help itch sensation?
Cooling pathways are a real area of itch research. TRPM8 activation has been studied clinically, and menthol is one ingredient that activates this cold-sensing receptor.
Can a topical botanical replace an antihistamine?
Topical botanicals and antihistamines belong to different categories. Antihistamines directly target histamine-driven urticaria, while topical botanical formulas are better understood through their ingredient research on itch, cooling and skin comfort.
Related articles
Clinical references
- Zuberbier T et al. International EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for urticaria. Allergy. 2022;77(3):734-766. PMID 34536239
- Clinical practice guideline for H1 antihistamine-resistant chronic spontaneous urticaria. 2025. PMID 41182242
- Sun XY et al. Antipruritic effect of osthole through selective inhibition of TRPV3. PMID 30108138
- Misery L et al. Anti-itching effects of a TRPM8 agonist cream in atopic dermatitis. PMID 30067875
- Dai H et al. A clinical and mechanistic study of topical borneol-induced analgesia. PMC5452010